(Q39478636)

12 September 2017

title

An objective method to estimate the severity of Raynaud phenomenon: digital blood pressure response to cooling (English)

1 reference

12 September 2017

H R Maricq

1

1 reference

12 September 2017

I Valter

series ordinal

2

1 reference

12 September 2017

J G Maricq

series ordinal

3

1 reference

12 September 2017

publication date

1 January 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

3

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

109-113

1 reference

Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, in treatment of Raynaud's phenomenon.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358836X9800300204

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X9800300204

Prazosin treatment of primary Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X9800300204

Raynaud phenomena and finger systolic pressure during cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X9800300204

The effect of local cooling on digital systolic pressure in patients with Raynaud's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358836X9800300204

10.1177/1358836X9800300204

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference